April 13, 2021
Rapid Dose Therapeutics Signs Exclusive Manufacturing And Distribution Agreement With Maplex Naturals Inc.
Sign up to get full access to all our latest Press Releases
Sign UpSign up to get full access to all our latest Press Releases
Sign UpUpdates
Press Releases
Capital Structure
RAPID DOSE THERAPEUTICS INC.
Listing/Symbol: CSE: DOSE
Fiscal Year-End: February 28
Auditors: MNP
Legal Counsel:
OwenBird Law Corporations,
c/o Jeffrey Lightfoot
Share Structure
Shares Issued & Outstanding: 77,067,435
Warrants: 740,000
Options: 0
As of January 21, 2020
Stock Quote
Investor Relations
For inquiries
Pat McCarthy
Managing Director
Capital Markets
Email: pmccarthy@leedejonesgable.com
Phone: (416) 365-8012